These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20540569)

  • 1. Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse.
    Manna SK; Patterson AD; Yang Q; Krausz KW; Li H; Idle JR; Fornace AJ; Gonzalez FJ
    J Proteome Res; 2010 Aug; 9(8):4176-88. PubMed ID: 20540569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model.
    Manna SK; Patterson AD; Yang Q; Krausz KW; Idle JR; Fornace AJ; Gonzalez FJ
    J Proteome Res; 2011 Sep; 10(9):4120-33. PubMed ID: 21749142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of mass spectrometry-based metabolomics in identification of early noninvasive biomarkers of alcohol-induced liver disease using mouse model.
    Manna SK; Thompson MD; Gonzalez FJ
    Adv Exp Med Biol; 2015; 815():217-38. PubMed ID: 25427910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.
    Li HH; Tyburski JB; Wang YW; Strawn S; Moon BH; Kallakury BV; Gonzalez FJ; Fornace AJ
    Alcohol Clin Exp Res; 2014 Jun; 38(6):1520-31. PubMed ID: 24773203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics Reveals Gut Microbiota Contribute to PPARα Deficiency-Induced Alcoholic Liver Injury.
    Zhang T; Bao L; Zhao Q; Wu ZE; Dai M; Rao Q; Li F
    J Proteome Res; 2023 Jul; 22(7):2327-2338. PubMed ID: 37232578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemfibrozil disrupts lysophosphatidylcholine and bile acid homeostasis via PPARα and its relevance to hepatotoxicity.
    Liu A; Krausz KW; Fang ZZ; Brocker C; Qu A; Gonzalez FJ
    Arch Toxicol; 2014 Apr; 88(4):983-96. PubMed ID: 24385052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Metabolic Pathways and Metabolites in a C57BL/6J Mouse Model of Alcoholic Liver Disease.
    Ma T; Li Y; Zhu Y; Jiang S; Cheng C; Peng Z; Xu L
    Med Sci Monit; 2020 May; 26():e924602. PubMed ID: 32384076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease.
    Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Han SH; Yang YJ; Baik GH; Bang CS; Kim DJ; Suk KT
    Hepatol Int; 2024 Apr; 18(2):486-499. PubMed ID: 37000389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's in Metabolomics for Alcoholic Liver Disease?
    Suciu AM; Crisan DA; Procopet BD; Radu CI; Socaciu C; Tantau MV; Stefanescu HO; Grigorescu M
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):51-58. PubMed ID: 29557415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics analysis of urine from patients with alcohol-associated liver disease reveals dysregulated caffeine metabolism.
    Xu R; He L; Vatsalya V; Ma X; Kim S; Mueller EG; Feng W; McClain CJ; Zhang X
    Am J Physiol Gastrointest Liver Physiol; 2023 Feb; 324(2):G142-G154. PubMed ID: 36513601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress.
    Okiyama W; Tanaka N; Nakajima T; Tanaka E; Kiyosawa K; Gonzalez FJ; Aoyama T
    J Hepatol; 2009 Jun; 50(6):1236-46. PubMed ID: 19398233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in mice.
    Charkoftaki G; Tan WY; Berrios-Carcamo P; Orlicky DJ; Golla JP; Garcia-Milian R; Aalizadeh R; Thomaidis NS; Thompson DC; Vasiliou V
    Chem Biol Interact; 2022 Jun; 360():109931. PubMed ID: 35429548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary metabolic profiling of rat models revealed protective function of scoparone against alcohol induced hepatotoxicity.
    Zhang A; Sun H; Wang X
    Sci Rep; 2014 Oct; 4():6768. PubMed ID: 25341677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Metabolomics Reveals a Protective Role for Basal PPARα in Cholestasis Induced by α-Naphthylisothiocyanate.
    Dai M; Hua H; Lin H; Xu G; Hu X; Li F; Gonzalez FJ; Liu A; Yang J
    J Proteome Res; 2018 Apr; 17(4):1500-1508. PubMed ID: 29498526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished Hepatocarcinogenesis by a Potent, High-Affinity Human PPARα Agonist in PPARA-Humanized Mice.
    Foreman JE; Koga T; Kosyk O; Kang BH; Zhu X; Cohen SM; Billy LJ; Sharma AK; Amin S; Gonzalez FJ; Rusyn I; Peters JM
    Toxicol Sci; 2021 Aug; 183(1):70-80. PubMed ID: 34081128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic metabolic profiling of urine biomarkers in rats with alcohol‑induced liver damage following treatment with Zhi‑Zi‑Da‑Huang decoction.
    An L; Lang Q; Shen W; Shi Q; Feng F
    Mol Med Rep; 2016 Sep; 14(3):2093-100. PubMed ID: 27430289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High resolution metabolomics technology reveals widespread pathway changes of alcoholic liver disease.
    Zhang A; Yan G; Zhou X; Wang Y; Han Y; Guan Y; Sun H; Wang X
    Mol Biosyst; 2016 Jan; 12(1):262-73. PubMed ID: 26593868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport.
    Xie C; Takahashi S; Brocker CN; He S; Chen L; Xie G; Jang K; Gao X; Krausz KW; Qu A; Levi M; Gonzalez FJ
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1396-1411. PubMed ID: 31195146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput metabolomics approach reveals new mechanistic insights for drug response of phenotypes of geniposide towards alcohol-induced liver injury by using liquid chromatography coupled to high resolution mass spectrometry.
    Zhang T; Zhang A; Qiu S; Sun H; Han Y; Guan Y; Wang X
    Mol Biosyst; 2016 Dec; 13(1):73-82. PubMed ID: 27896352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics approach based on utra-performance liquid chromatography coupled to mass spectrometry with chemometrics methods for high-throughput analysis of metabolite biomarkers to explore the abnormal metabolic pathways associated with myocardial dysfunction.
    Zhao LK; Zhao YB; Yu PC; Zhang PX
    Biomed Chromatogr; 2020 Aug; 34(8):e4847. PubMed ID: 32285481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.